• Raising the profile and impact of endovascular vascular research
• Developing the research leaders of the future
• Increasing investment in research activities and programmes of study through sustainable research funding streams.

The BSET Pump Priming award is to support a research project within the field of endovascular therapy. The award can be used for a stand-alone project, or to compliment an existing body of research which is either planned, or already underway.

2026 BSET Pump Priming Awardees

Tom Lyons

Tom Lyons of Birmingham Heartlands Hospital will undertake research on Artificial Intelligence in Peripheral Arterial Disease (aiPAD): Automated assignment of TASC II and GLASS scores from infrainguinal Digital Subtraction Angiography using supervised machine learning.

 

Holly Watson

Holly Watson from Manchester Royal Infirmary will undertake research on Duplex follow up of Aortic Arch branched TEVAR

2025 BSET Pump Priming Awardees

Sarah Sillito of Freeman Hospital, Newcastle whose research is entitled BEACON Study – Beetroot Evaluation and Acceptability on Clinical Outcomes in lower limb eNdovascular intervention


Arsalan Wafi of Guy’s & St Thomas’ Hospital, London whose research is Personalised Prediction of Restenosis Risk Through Integrated IVUS-Based Computational Flow Dynamics and Microfluidic Flow System Experimentation



2024 BSET Pump Priming Awardees  

Mohamed Abdelhalim 

Mohamed’s research is on the effects of implanting aortic stent grafts on aortic stiffness and cardiac function at KCL.

James Budge

James’ research will focus on developing and evaluating the face, content and construct validity of the St George’s Vascular Institute (SGVI) EndoSim V2.

BSET has supported new research evaluating long-term outcomes (>10 years) for FEVAR from GLOBALSTAR registry data (Global Collaborators on Advanced Stent-Graft Techniques for Aneurysm Repair).

 

The BSET-CLEVAR registry is a prospective, multi-centre, observational cohort study of patients treated with the GORE EXCLUDER Conformable AAA Endoprosthesis with ACTIVE CONTROL System (EXCC Device)

The primary objective of the registry is to collect real-world clinical data and device-specific outcomes of EXCC Device in routine clinical treatment of patients with abdominal aortic aneurysm (AAA)

Further information

Individuals wishing to circulate questionnaires or surveys to the BSET membership are requested to send the following to the BSET office:

  • A one page summary of the research project and its use
  • The lead name of the institution and contributors to the research
  • Any conflicts of interest/external or industry funding

Those who request that their questionnaires/surveys be circulated to the membership are encouraged to submit the results for consideration as an abstract/poster at the BSET Annual Meeting.